Valeo Financial Advisors’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $450K | Sell |
10,535
-2,030
| -16% | -$110K | 0.01% | 477 |
|
|
2026
Q1 | $789K | Sell |
12,565
-8,074
| -39% | -$646K | 0.02% | 305 |
|
|
2025
Q4 | $1.97M | Sell |
20,639
-1,957
| -9% | -$192K | 0.04% | 174 |
|
|
2025
Q3 | $2.21M | Buy |
22,596
+45
| +0.2% | +$4.66K | 0.05% | 155 |
|
|
2025
Q2 | $2.42M | Buy |
22,551
+930
| +4% | +$94.1K | 0.06% | 151 |
|
|
2025
Q1 | $2.18M | Buy |
21,621
+1,644
| +8% | +$166K | 0.06% | 144 |
|
|
2024
Q4 | $1.78M | Sell |
19,977
-375
| -2% | -$33K | 0.05% | 164 |
|
|
2024
Q3 | $1.71M | Buy |
20,352
+49
| +0.2% | +$3.86K | 0.05% | 174 |
|
|
2024
Q2 | $1.56M | Sell |
20,303
-948
| -4% | -$69.4K | 0.05% | 175 |
|
|
2024
Q1 | $1.55M | Buy |
21,251
+165
| +0.8% | +$10.6K | 0.06% | 176 |
|
|
2023
Q4 | $1.22M | Buy |
21,086
+2,980
| +16% | +$159K | 0.05% | 197 |
|
|
2023
Q3 | $956K | Buy |
18,106
+4,424
| +32% | +$232K | 0.04% | 214 |
|
|
2023
Q2 | $740K | Buy |
13,682
+1,134
| +9% | +$59.2K | 0.03% | 246 |
|
|
2023
Q1 | $628K | Buy |
12,548
+3,517
| +39% | +$166K | 0.03% | 287 |
|
|
2022
Q4 | $418K | Sell |
9,031
-3,935
| -30% | -$170K | 0.02% | 310 |
|
|
2022
Q3 | $502K | Buy |
+12,966
| New | +$520K | 0.03% | 261 |
|
|
2022
Q2 | – | Sell |
-5,843
| Closed | -$259K | – | 537 |
|
|
2022
Q1 | $259K | Buy |
5,843
+484
| +9% | +$21K | 0.01% | 480 |
|
|
2021
Q4 | $228K | Buy |
5,359
+120
| +2% | +$5.04K | 0.01% | 485 |
|
|
2021
Q3 | $227K | Buy |
5,239
+318
| +6% | +$14.1K | 0.01% | 467 |
|
|
2021
Q2 | $210K | Buy |
4,921
+85
| +2% | +$3.58K | 0.01% | 437 |
|
|
2021
Q1 | $187K | Sell |
4,836
-203
| -4% | -$7.68K | 0.01% | 454 |
|
|
2020
Q4 | $181K | Hold |
5,039
| – | – | 0.01% | 434 |
|
|
2020
Q3 | $193K | Sell |
5,039
-306
| -6% | -$11.8K | 0.02% | 336 |
|
|
2020
Q2 | $188K | Sell |
5,345
-155
| -3% | -$5.58K | 0.02% | 335 |
|
|
2020
Q1 | $199K | Sell |
5,500
-1,104
| -17% | -$43.1K | 0.02% | 302 |
|
|
2019
Q4 | $299K | Buy |
6,604
+490
| +8% | +$20.5K | 0.03% | 252 |
|
|
2019
Q3 | $249K | Buy |
6,114
+1,741
| +40% | +$73.8K | 0.03% | 262 |
|
|
2019
Q2 | $188K | Hold |
4,373
| – | – | 0.02% | 300 |
|
|
2019
Q1 | $168K | Buy |
4,373
+144
| +3% | +$5.5K | 0.02% | 316 |
|
|
2018
Q4 | $149K | Sell |
4,229
-246
| -5% | -$8.92K | 0.02% | 302 |
|
|
2018
Q3 | $162K | Buy |
4,475
+62
| +1% | +$2.17K | 0.02% | 306 |
|
|
2018
Q2 | $147K | Sell |
4,413
-838
| -16% | -$25.3K | 0.02% | 334 |
|
|
2018
Q1 | $143K | Buy |
5,251
+175
| +3% | +$4.76K | 0.02% | 295 |
|
|
2017
Q4 | $126K | Buy |
5,076
+330
| +7% | +$9.1K | 0.02% | 301 |
|
|
2017
Q3 | $138K | Buy |
+4,746
| New | +$131K | 0.03% | 245 |
|
Other funds holding BSX
Valeo Financial Advisors's BSX Position: Q2 2026 in Review
Valeo Financial Advisors reduced its Boston Scientific (BSX) stake by 16% in Q2 2026, selling an estimated $110K and leaving 10,535 shares worth $450K. The position accounts for 0.01% of the portfolio, ranked #477.
Valeo Financial Advisors first reported a position in BSX in Q3 2017 and has held it in 35 quarters since. The position peaked at $2.42M in Q2 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Valeo Financial Advisors held 10,535 shares of Boston Scientific worth $450K as of Q2 2026.
- Valeo Financial Advisors sold 2,030 Boston Scientific shares in Q2 2026, an estimated $110K.
- Boston Scientific made up 0.01% of Valeo Financial Advisors's portfolio in Q2 2026, its #477 holding.
- Valeo Financial Advisors first reported a position in Boston Scientific in Q3 2017 and has held it in 35 quarters since.
- Valeo Financial Advisors's Boston Scientific position peaked at $2.42M in Q2 2025.
- 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Valeo Financial Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.